Clinical trial
Post Marketing Surveillance Study of Dysport
NCT00210431 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00210431 |
|---|---|
| Title | Post Marketing Surveillance Study of Dysport |
| Official title | A Post Marketing Surveillance Study of Dysport Formulated With a Batch of Bulk Active Substance From a New Primary Manufacturing Facility at the Centre for Applied Microbiology & Research (CAMR) |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Blepharospasm, Hemifacial Spasm, Cervical Dystonia, Spasmodic Torticollis, Cerebral Palsy, Muscle Spasticity, Cerebrovascular Accident, Equinus Deformity, Facial Hyperdynamic Lines |
| Enrollment | 783 |
| Start date | Oct 1, 2004 |
| Completion | Jun 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 31, 2020 |
| Countries | France, Germany, Russia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: